Bionano Genomics

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$7,367
$6,733
$6,457
$8,163
Gross Profit
3,525
3,477
2,938
3,417
EBITDA
-6,062
-4,343
-525
-17,648
EBIT
-8,489
-6,774
-3,010
-20,097
Net Income
-8,503
-6,857
-3,102
-20,125
Net Change In Cash
7,367
6,733
6,457
8,163
Free Cash Flow
-5,919
-3,487
-2,764
-6,504
Cash
3,065
3,562
3,625
9,173
Basic Shares
5,338
3,441
2,694
1,902

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$30,776
$36,116
$27,802
$17,981
Gross Profit
380
9,566
5,945
3,874
EBITDA
-97,469
-213,604
-120,315
-73,855
EBIT
-111,695
-227,312
-130,414
-77,225
Net Income
-112,017
-232,493
-132,596
-72,435
Net Change In Cash
30,776
36,116
27,802
17,981
Cost of Revenue
-19,042
-13,878
Free Cash Flow
-69,025
-126,872
-128,118
-73,387
Cash
9,173
17,948
5,091
24,571
Basic Shares
1,902
580
491
470

Earnings Calls

QuarterEPS
2025-09-30
-$1.59
2025-06-30
-$1.99
2025-03-31
-$10.78
2024-12-31
-$7.73